The Berkowitz Law Firm LLC Announces that it is Evaluating Potential Testosterone Therapy Claims

As the FDA investigates the potential risk of stroke, heart attack and death among men who use testosterone replacement therapy, the Connecticut defective drug lawyers of The Berkowitz Law Firm LLC announce they are evaluating potential testosterone therapy claims.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
berkowitzlaw-testosterone-therapy-attorney
Our lawyers are currently investigating potential lawsuits on behalf of men who have been prescribed testosterone replacement therapy products and who have suffered heart complications such as heart attack and stroke

Stamford, Connecticut (PRWEB) May 20, 2014

The Connecticut defective drug lawyers of The Berkowitz Law Firm LLC are announcing that they are evaluating testosterone therapy claims on behalf of men who have suffered alleged injuries as a result of testosterone therapy products.

The U.S. Food and Drug Administration (FDA) issued a safety announcement Jan. 21, 2014 notifying the public of its plans to investigate the potential risk of stroke, heart attack and death in men who use testosterone therapy products. The agency said its decision to reassess the safety of low-T products is based on results from two separate studies that suggest testosterone replacement therapy may be linked to an increase in the risk for serious cardiovascular events.*

Testosterone replacement therapy products, although only approved to treat symptoms of low testosterone levels associated with conditions such as hypogonadism, have been prescribed to men for complaints of symptoms associated with normal aging. In fact, according to an article published May 8, 2014 by CBS, sales of testosterone replacement drugs have surpassed those of Viagra, raking in more than $1.6 billion in the U.S.**

“Our lawyers are currently evaluating claims on behalf of men who have been prescribed testosterone replacement therapy products and who have suffered heart complications such as heart attack and stroke,” said Russell Berkowitz, Founding Partner of The Berkowitz Law Firm LLC.

According to the FDA’s safety announcement, the first study that prompted its investigation into the safety of testosterone replacement involved an analysis of older men in the U.S. Veterans Affairs health system. The study, which was published in the November 2013 issue of the Journal of the American Medical Association (JAMA), suggests a 30 percent greater risk of stroke, heart attack and death in men that use testosterone replacement. ***

A second study reported a two-fold increased risk for heart attack in men older than 65 years and a two- to three-fold increase risk for heart attack in men younger than 65 who have a history of heart disease.****

In light of the FDA’s investigation into the safety of these drugs, The Berkowitz Law Firm LLC reports that it is evaluating claims on behalf of men who have allegedly suffered heart problems and who have a history of using testosterone therapy products, including:

  • Androgel
  • Androderm
  • Axirom
  • Bio-T-Gel
  • Delatestry
  • Depo-Testosterone
  • Fortesta
  • Striant
  • Testim
  • Testopel

For more information or to speak with a Connecticut personal injury lawyer about a possible claim, contact The Berkowitz Law Firm LLC today.

Sources:

*http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm?utm_source=rss&utm_medium=rss&utm_campaign=fda-evaluating-risk-of-stroke-heart-attack-and-death-with-fda-approved-testosterone-products

** http://denver.cbslocal.com/2014/05/08/low-t-patients-poised-to-sue-drug-makers/

***Vigen R, O'Donnell CI, Baron AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829-1836.

****http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805


Contact

Follow us on: Contact's Google Plus